comprehensive -WSS

comprehensive

author：explore 2025-09-06 04:51:39 - browse：13316

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： A solution to the after

explore

WSS

Another man arrested in connection with shooting at Kansas nightclub

Dario to buy mental health app maker Twill in cash and stock deal

Sen. Bill Cassidy on how to lower drug prices

Medicare inequities exacerbate Puerto Rico’s health disparities

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Wikipedia

comprehensive

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

US intelligence assessment says Iran not currently developing nuclear weapons

Continuity nursing helped my family in our darkest PICU moments

New documents shed light on MD Anderson Cancer Institute feud

Bright Health sells Medicare Advantage business to Molina

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Novavax promises a turnaround & Lilly roils the obesity market

Obesity drugs seen as possible treatment for liver disease MASH

Drug repurposing or repositioning? The language matters

Titanic submersible: What a 'catastrophic implosion' means and what officials found

hotspot

Sen. Bill Cassidy on how to lower drug prices

Neutralizing antibodies against HIV shows promise in children

With fresh data, a dynamic duo powers Eli Lilly to new heights

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

NIH study of ME/CFS points to clear biological hallmarks

A solution to the after

entertainment

explore

Wikipedia

focus